 Recent studies support the hypothesis that aortic stenosis AS develops due to atherosclerosis affecting the aortic valve endothelium. The studys aim was to assess Rosuvastatin on the hemodynamic progression and inflammatory markers of AS by treating low-density lipoprotein LDL in patients with AS according to the National Cholesterol Education Program Adult Treatment Panel III NCEP-ATPIII guidelines for one year. 